WO2012173358A3 - 정소의 체세포-유래의 다능성 줄기세포, 이의 제조방법 및 이를 포함하는 발기부전 치료용 약학 조성물 - Google Patents

정소의 체세포-유래의 다능성 줄기세포, 이의 제조방법 및 이를 포함하는 발기부전 치료용 약학 조성물 Download PDF

Info

Publication number
WO2012173358A3
WO2012173358A3 PCT/KR2012/004546 KR2012004546W WO2012173358A3 WO 2012173358 A3 WO2012173358 A3 WO 2012173358A3 KR 2012004546 W KR2012004546 W KR 2012004546W WO 2012173358 A3 WO2012173358 A3 WO 2012173358A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
somatic cell
pluripotent stem
pharmaceutical composition
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/004546
Other languages
English (en)
French (fr)
Other versions
WO2012173358A2 (ko
Inventor
이동율
최원윤
윤태기
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of College of Medicine Pochon CHA University
Original Assignee
Industry Academic Cooperation Foundation of College of Medicine Pochon CHA University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation of College of Medicine Pochon CHA University filed Critical Industry Academic Cooperation Foundation of College of Medicine Pochon CHA University
Priority to US14/126,220 priority Critical patent/US9688961B2/en
Priority to CN201280029658.4A priority patent/CN103620023B/zh
Publication of WO2012173358A2 publication Critical patent/WO2012173358A2/ko
Publication of WO2012173358A3 publication Critical patent/WO2012173358A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0683—Cells of the male genital tract, e.g. prostate, epididymis; Non-germinal cells from testis, e.g. Leydig cells, Sertoli cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

본 발명은 정소의 체세포-유래의 다능성 줄기세포, 더욱 상세하게는 CD34 및 CD73 모두에 대하여 양성 면역 반응을 나타내고, 정소의 체세포로부터 유래된, 다능성 성체줄기세포를 제공한다. 또한, 본 발명은 상기 정소의 체세포-유래의 다능성 줄기세포의 제조방법 및 이를 포함하는 발기부전 치료용 약학 조성물을 제공한다.
PCT/KR2012/004546 2011-06-15 2012-06-08 정소의 체세포-유래의 다능성 줄기세포, 이의 제조방법 및 이를 포함하는 발기부전 치료용 약학 조성물 Ceased WO2012173358A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/126,220 US9688961B2 (en) 2011-06-15 2012-06-08 Process of preparing human multipotent stem cells co-expressing CD34 and CD73
CN201280029658.4A CN103620023B (zh) 2011-06-15 2012-06-08 睾丸体细胞来源的多能干细胞、其制备方法以及包含其的治疗勃起功能障碍的药物组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110057767 2011-06-15
KR10-2011-0057767 2011-06-15

Publications (2)

Publication Number Publication Date
WO2012173358A2 WO2012173358A2 (ko) 2012-12-20
WO2012173358A3 true WO2012173358A3 (ko) 2013-02-07

Family

ID=47357578

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/004546 Ceased WO2012173358A2 (ko) 2011-06-15 2012-06-08 정소의 체세포-유래의 다능성 줄기세포, 이의 제조방법 및 이를 포함하는 발기부전 치료용 약학 조성물

Country Status (4)

Country Link
US (1) US9688961B2 (ko)
KR (1) KR101429110B1 (ko)
CN (1) CN103620023B (ko)
WO (1) WO2012173358A2 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101781173B1 (ko) 2014-10-17 2017-09-22 경희대학교 산학협력단 면역 억제능이 증진된 중간엽 줄기 세포 및 이의 제조방법
CN105331579A (zh) * 2015-11-27 2016-02-17 中山大学 人睾丸间质干细胞的分离、培养方法及其用途
CN105902568A (zh) * 2016-04-29 2016-08-31 张宁 用于治疗勃起功能障碍的脂肪间充质干细胞
CN108588004A (zh) * 2018-04-09 2018-09-28 深圳市莱利赛生物科技有限公司 诱导分化睾丸间质细胞的方法及其在性功能恢复中的应用
JP2022501017A (ja) * 2018-09-07 2022-01-06 チャ バイオテック カンパニー リミテッド 多能性幹細胞由来の間葉系幹細胞直接分化用培地、それを利用して間葉系幹細胞を製造する方法、及びそれによって製造された間葉系幹細胞
CN113662968B (zh) * 2021-09-18 2023-09-19 哈尔滨科技实业开发有限公司 一种用于治疗勃起功能障碍的药物组合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070030774A (ko) * 2006-10-13 2007-03-16 학교법인 성광학원 생식줄기세포의 체외 분리, 증식 및 분화 방법
US20110008764A1 (en) * 2009-06-02 2011-01-13 Davinci Biosciences Llc Human gonadal stem cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052177A2 (en) * 2002-12-05 2004-06-24 Case Western Reserve University Cell-based therapies for ischemia
WO2004092357A1 (ja) * 2003-04-15 2004-10-28 Kyoto University 精子幹細胞の生体外における増殖方法、その方法を利用して増殖された精子幹細胞、および精子幹細胞の生体外増殖に用いられる培地添加剤キット
US20080044395A1 (en) 2004-04-13 2008-02-21 Sungkwang Educational Foundation In Vitro Method for Isolating, Proliferating and Differentiating Germ-Line Stem Cells

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070030774A (ko) * 2006-10-13 2007-03-16 학교법인 성광학원 생식줄기세포의 체외 분리, 증식 및 분화 방법
US20110008764A1 (en) * 2009-06-02 2011-01-13 Davinci Biosciences Llc Human gonadal stem cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GONZALEZ ET AL.: "A putative mesenchymal stem cells population isolated from adult human testes", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 385, 29 May 2009 (2009-05-29), pages 570 - 575 *
LIM ET AL.: "Ling-term proliferation and characterization of human spermatogonial stemcells obtained from obstructive and non-obstructive azoospermia under exogenous feeder-free culture conditions", CELL PROLIFERATION, vol. 43, 2010, pages 405 - 417 *

Also Published As

Publication number Publication date
CN103620023A (zh) 2014-03-05
KR101429110B1 (ko) 2014-08-12
KR20120140197A (ko) 2012-12-28
US20140120070A1 (en) 2014-05-01
WO2012173358A2 (ko) 2012-12-20
US9688961B2 (en) 2017-06-27
CN103620023B (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
MD20150091A2 (ro) Compuşi antivirali
WO2014124087A8 (en) Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
WO2012006440A3 (en) Endothelial cell production by programming
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
HK1222205A1 (zh) 由多能干细胞产生的光感受器和光感受器袓细胞
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
WO2012109208A3 (en) Hematopoietic precursor cell production by programming
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
MX339533B (es) Composiciones y metodos de daclizumab (dac) del proceso de alto rendimiento (hyp).
WO2012156998A3 (en) Amorphous mirabegron and processes for crystal forms of mirabegron
AU2012209332A8 (en) Methods and compositions for preparing noribogaine from voacangine
WO2012058243A3 (en) Cell fate conversion of differentiated somatic cells into glial cells
WO2013049459A3 (en) Somatic stem cells
WO2010092090A3 (en) Novel salts of sitagliptin
WO2012173358A3 (ko) 정소의 체세포-유래의 다능성 줄기세포, 이의 제조방법 및 이를 포함하는 발기부전 치료용 약학 조성물
MX2014002996A (es) Anticuerpos anti - egfr/anti - igf-1r bisespecificos.
WO2012136898A3 (en) Novel cutinases, their production and uses
WO2014057498A3 (en) Process for the preparation of cobicistat intermediates
WO2013068850A3 (en) PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES
WO2013164839A3 (en) Amorphous form of apixaban, process of preparation and compositions thereof
HK1199896A1 (en) Novel compositions for producing cast polyamides
WO2014068586A3 (en) Solid oral compositions of tolvaptan
WO2012131707A3 (en) Crystalline form of bortezomib, preparation method and pharmaceutical composition there f
WO2012063269A3 (en) Process for preparing iloperidone

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12800231

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14126220

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12800231

Country of ref document: EP

Kind code of ref document: A2